October 02, 2013

Andrulis Pharmaceuticals Corp. v. Celgene Corp.

Track this case

Case Number:

1:13-cv-01644

Court:

Delaware

Nature of Suit:

Patent

Judge:

Richard G. Andrews

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. April 11, 2014

    Celgene Gets Claims Trimmed From Andrulis Drug Patent Suit

    A Delaware federal judge on Thursday trimmed Andrulis Pharmaceuticals Corp.’s suit accusing rival drugmaker Celgene Corp. of infringing its patent covering a bone marrow cancer treatment, ruling a direct infringement claim was implausible.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS